NCT04062162

Brief Summary

Androgen deprivation therapy (ADT) is widely used in men with prostate cancer (PCa) to delay disease progression and enhance survival. The use of ADT is often associated with a vast spectrum of side effects that considerably reduce quality of life. Exercise has been proposed as a non-pharmacological strategy to counter some adverse effects of ADT among patients with PCa. Particularly, recreational football-based interventions have been suggested as an enjoyment approach to involve patients with PCa in regular exercise practice. Given its intermittent nature and vigorous efforts, adverse events associated with recreational football practice have been reported. To handle this issue and to involve patients with PCa in recreational football practice, walking football has emerged as a more suitable exercise modality

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable prostate-cancer

Timeline
Completed

Started Jul 2019

Shorter than P25 for not_applicable prostate-cancer

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 11, 2019

Completed
28 days until next milestone

First Submitted

Initial submission to the registry

August 8, 2019

Completed
12 days until next milestone

First Posted

Study publicly available on registry

August 20, 2019

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2020

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2020

Completed
Last Updated

January 13, 2020

Status Verified

January 1, 2020

Enrollment Period

11 months

First QC Date

August 8, 2019

Last Update Submit

January 9, 2020

Conditions

Keywords

Prostate CancerAndrogen Deprivation TherapyWalking football

Outcome Measures

Primary Outcomes (6)

  • Recruitment rate.

    Assessed by the number of enrolled patients divided by the number of invited patients.

    Baseline

  • Withdrawal rate

    Assessed by the number of withdrawal patients

    Change from baseline to 32 weeks

  • Appropriateness of outcomes assessments.

    Assessed by the percentage of completed data.

    Change from baseline to 32 weeks

  • Adherence to intervention.

    Assessed by the number of completed sessions and the number of missed sessions.

    Change from baseline to 32 weeks

  • Rate of Enjoyment

    Assessed by the self-reported exercise sessions' enjoyment using a likert scale (1 \[lowest\] to 5 \[highest\] points).

    Change from baseline to 32 weeks

  • Health-related quality of life

    Using EORTC PR25, EQ-5D-5L and SF-6D questionnaire.

    Change from baseline to 32 weeks

Secondary Outcomes (29)

  • Bone Mineral Density

    Change from baseline to 32 weeks

  • Body composition

    Change from baseline to 32 weeks

  • Aerobic capacity

    Change from baseline to 32 weeks

  • Maximal isometric handgrip strength

    Change from baseline to 32 weeks

  • Maximal isometric lower limb strength

    Change from baseline to 32 weeks

  • +24 more secondary outcomes

Study Arms (2)

Interventional group

ACTIVE COMPARATOR

Walking football training

Behavioral: Walking football training

Control group

NO INTERVENTION

Usual care

Interventions

Intervention will involve 3 sessions per week of a structured and supervised walking football program over 16 weeks. Each session will include a warm-up, followed by the practice of specific exercises where specific technical skills (pass, dribble, shot), motor skills (agility, coordination, balance) and physical fitness (cardiorespiratory and musculoskeletal capacity) will be enhanced, ending with a structured game (7x7) of walking football and a cooldown.

Also known as: Exercise training
Interventional group

Eligibility Criteria

Age18 Years - 85 Years
Sexmale(Gender-based eligibility)
Gender Eligibility DetailsMale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients diagnosed with PCa
  • Under castration therapy for more than 3 months
  • Planned to be under castration for more than 6 months
  • Follow-up at the Medical Oncology department and/or Urology department of the Hospital Center Vila Nova de Gaia/Espinho.

You may not qualify if:

  • Medical or surgical contraindications for exercise.
  • T-score \< -2.5

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centro Hospitalar Vila Nova de Gaia / Espinho

Vila Nova de Gaia, Portugal

Location

Related Publications (1)

  • Capela A, Antunes P, Coelho CA, Garcia CL, Custodio S, Amorim R, Costa T, Vilela E, Teixeira M, Amarelo A, Silva J, Joaquim A, Viamonte S, Brito J, Alves AJ. Effects of walking football on adherence, safety, quality of life and physical fitness in patients with prostate cancer: Findings from the PROSTATA_MOVE randomized controlled trial. Front Oncol. 2023 Mar 21;13:1129028. doi: 10.3389/fonc.2023.1129028. eCollection 2023.

MeSH Terms

Conditions

Prostatic Neoplasms

Interventions

Exercise

Condition Hierarchy (Ancestors)

Genital Neoplasms, MaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsGenital Diseases, MaleGenital DiseasesUrogenital DiseasesProstatic DiseasesMale Urogenital Diseases

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Andreia Capela, MD

    Centro Hospitalar Vila Nova de Gaia / Espinho, EPE

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical oncologist at Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E.

Study Record Dates

First Submitted

August 8, 2019

First Posted

August 20, 2019

Study Start

July 11, 2019

Primary Completion

May 31, 2020

Study Completion

June 30, 2020

Last Updated

January 13, 2020

Record last verified: 2020-01

Data Sharing

IPD Sharing
Will not share

Locations